Academy member physicians presented coverage recommendations this week to medical directors for the CGS, NGS, and Palmetto Medicare jurisdictions for both minimally invasive glaucoma surgery (MIGS) and medical botulinum toxin injections.
Member exclusive - Locked
Log in to keep reading.
Join AAO to get unlimited access to content. See member benefits or join today.